Natural outcome of trisomy 13, trisomy 18, and triploidy after prenatal diagnosis

American Journal of Medical Genetics, Part A

Volumn 155, Issue 11, 2011, Pages 2626-2633

  Lakovschek, Ioana Claudia ^a   Streubel, Berthold ^b   Ulm, Barbara ^a  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Natural outcome; Prenatal diagnosis; Triploidy; Trisomy 13; Trisomy 18

Indexed keywords

AMNIOCENTESIS; ARTICLE; BIRTH RATE; CHORION VILLUS SAMPLING; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; INFANT; LIFESPAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PUERPERIUM; SURVIVAL RATE; TRIPLOIDY; TRISOMY 13; TRISOMY 18;

ABORTION, INDUCED; ADULT; AMNIOCENTESIS; BIRTH RATE; CHORIONIC VILLI SAMPLING; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; FETAL DEATH; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; KARYOTYPE; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; TRIPLOIDY; TRISOMY; YOUNG ADULT;

EID: 80054905644     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.34284     Document Type: Article

References (63)

1. Al-Alaiyan S, Al-Hazzani F. 2009. The need for hospital-based neonatal palliative care programs in Saudi Arabia. Ann Saudi Med 29:337-341.
2. Baty BJ, Blackburn BL, Carey JC. 1994. Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 49:175-188.
3. Baumer A, Balmer D, Binkert F, Schinzel A. 2000. Parental origin and mechanisms of formation of triploidy: A study of 25 cases. Eur J Hum Genet 8:911-917.
4. Berger TM, Hofer A. 2009. Causes and circumstances of neonatal deaths in 108 consecutive cases over a 10-year period at the Children's Hospital of Lucerne, Switzerland. Neonatology 95:157-163.
5. Brancati F, Mingarelli R, Dallapiccola B. 2003. Recurrent triploidy of maternal origin. Eur J Hum Genet 11:972-974.
6. Brewer CM, Holloway SH, Stone DH, Carothers AD, FitzPatrick DR. 2002. Survival in trisomy 13 and trisomy 18 cases ascertained from population based registers. J Med Genet 39:e54.
7. Carter PE, Pearn JH, Bell J, Martin N, Anderson NG. 1985. Survival in trisomy 18. Clin Genet 27: 59-61.
8. Chitty LS, Barnes CA, Berry C. 1996. Continuing with pregnancy after a diagnosis of lethal abnormality: Experience of five couples and recommendations for management. BMJ 313:478-480.
9. De Vigan C, Baena N, Cariati E, Clementi M, Stoll C, EUROSCAN Working Group. 2001. Contribution of ultrasonographic examination to the prenatal detection of chromosomal abnormalities in 19 centres across Europe. Ann Genet 44:209-217.
10. Doshi N, Surti U, Szulman AE. 1983. Morphologic anomalies in triploid liveborn fetuses. Hum Pathol 14:716-723.
11. Drake H, Reid M, Marteau T. 1996. Attitudes towards termination for fetal abnormality: Comparisons in three European countries. Clin Genet 49:134-140.
12. Drugan A, Greb A, Johnson MP, Krivchenia EL, Uhlmann WR, Moghissi KS, Evans MI. 1990. Determinants of parental decisions to abort for chromosome abnormalities. Prenat Diagn 10:483-490.
13. Embleton ND, Wyllie JP, Wright MJ, Burn J, Hunter S. 1996. Natural history of trisomy 18. Arch Dis Child Fetal Neonatal Ed 75: (1):38-41.
14. Evans MI, Sobiecki MA, Krivchenia EL, Duquette DA, Drugan A, Hume RF, Jr, Johnson MP. 1996. Parental decisions to terminate/continue following abnormal cytogenetic prenatal diagnosis: "what" is still more important than "when". Am J Med Genet 61:353-355.
15. Forrester MB, Merz RD. 1999. Trisomies 13 and 18: Prenatal diagnosis and epidemiologic studies in Hawaii, 1986-1997. Genet Test 3:335-340.
16. Forrester MB, Merz RD. 2003a. First-year mortality rates for selected birth defects, Hawaii, 1986-1999. Am J Med Genet Part A 119A:311-318.
17. Forrester MB, Merz RD. 2003b. Epidemiology of triploidy in a population-based birth defects registry, Hawaii, 1986-1999. Am J Med Genet Part A 119A:319-323.
18. Goc B, Walencka Z, Włoch A, Wojciechowska E, Wiecek-Włodarska D, Krzystolik-Ładzińska J, Bober K, Swietliński J. 2006. Trisomy 18 in neonates: Prenatal diagnosis, clinical features, therapeutic dilemmas and outcome. J Appl Genet 47:165-170.
19. Goldstein H, Nielsen KG. 1988. Rates and survival of individuals with trisomy 13 and 18. Data from a 10-year period in Denmark. Clin Genet 34:366-372.
20. Graham JM, Jr, Rawnsley EF, Simmons GM, Wurster-Hill DH, Park JP, Marin-Padilla M, Crow HC. 1989. Triploidy: Pregnancy complications and clinical findings in seven cases. Prenat Diagn 9:409-419.
21. Grandjean H, Larroque D, Levi S. 1998. Detection of chromosomal abnormalities, an outcome of ultrasound screening. The Eurofetus Team. Ann N Y Acad Sci 847:136-140.
22. Hasegawa T, Harada N, Ikeda K, Ishii T, Hokuto I, Kasai K, Tanaka M, Fukuzawa R, Niikawa N, Matsuo N. 1999. Digynic triploid infant surviving for 46 days. Am J Med Genet 87:306-310.
23. Hassed SJ, Miller CH, Pope SK, Murphy P, Quirk JG, Cunniff C. 1993. Perinatl lethal conditions: The effect of diagnosis on decision making. Obstet Gynecol 82:37-42.
24. Hasslod T, Hunt P. 2001. To err (meiotically) is human: The genesis of human aneuploidy. Nat Rev Genet 2:280-291.
25. Hewison J, Green JM, Ahmed S, Cuckle HS, Hirst J, Hucknall C, Thornton JG. 2007. Attitudes to prenatal testing and termination of pregnancy for fetal abnormality: A comparison of white and Pakistani women in the UK. Prenat Diagn 27:419-430.
26. Holmes-Siedle M, Ryynanen M, Lindenbaum RH. 1987. Parental decisions regarding termination of pregnancy following prenatal detection of sex chromosome abnormality. Prenat Diagn 7:239-244.
27. Hook EB, Topol BB, Cross PK. 1989. The natural history of cytogenetically abnormal fetuses detected at midtrimester amniocentesis which are not terminated electively: New data and estimates of the excess and relative risk of late fetal death associated with 47, +21 and some other abnormal karyotypes. Am J Hum Genet 45:855-861.
28. Hsiao CC, Tsao LY, Chen HN, Chiu HY, Chang WC. 2009. Changing clinical presentations and survival pattern in trisomy 18. Pediatr Neonatol 50:147-151.
29. Huang T, Alberman E, Wald N, Summers AM. 2005. Triploidy identified through second-trimester serum screening. Prenat Diagn 25:229-233.
30. Huether CA, Martin RL, Stoppelman SM, D'Souza S, Bishop JK, Torfs CP, Lorey F, May KM, Hanna JS, Baird PA, Kelly JC. 1996. Sex ratios in fetuses and liveborn infants with autosomal aneuploidy. Am J Med Genet 63:492-500.
31. Irving C, Richmond S, Wren C, Longster C, Embleton ND. 2011. Changes in fetal prevalence and outcome for trisomies 13 and 18: A population-based study over 23 years. J Matern Fetal Neonatal Med 24(1):137-141.
32. Jacobs PA, Hassold TJ, Matsuyama AM, Newlands IM. 1978. Chromosome constitution of gestational trophoblastic disease. Lancet 2:49.
33. Jacobs PA, Szulman AE, Funkhouser J, Matsuura JS, Wilson CC. 1982. Human triploidy: Relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet 46:223-231.
34. Jauniaux E, Brown R, Rodeck C, Nicolaides KH. 1996. Prenatal diagnosis of triploidy during the second trimester of pregnancy. Obstet Gynecol 88:983-989.
35. Leung TN, Ching Chau MM, Chang JJ, Leung TY, Fung TY, Lau TK. 2004. Attitudes towards termination of pregnancy among Hong Kong Chinese women attending prenatal diagnosis counselling clinic. Prenat Diagn 24:546-551.
36. Lin HY, Lin SP, Chen YJ, Hung HY, Kao HA, Hsu CH, Chen MR, Chang JH, Ho CS, Huang FY, Shyur SD, Lin DS, Lee HC. 2006. Clinical characteristics and survival of trisomy 18 in a medical center in Taipei, 1988-2004. Am J Med Genet Part A 140A:945-951.
37. McFadden DE, Kalousek DK. 1991. Two different phenotypes of fetuses with chromosomal triploidy: Correlation with parental origin of the extra haploid set. Am J Med Genet 38:535-538.
38. McGraw MP, Perlman JM. 2008. Attitudes of neonatologists toward delivery room management of confirmed trisomy 18: Potential factors influencing a changing dynamic. Pediatrics 121:1106-1110.
39. McWeeney DT, Munné S, Miller RC, Cekleniak NA, Contag SA, Wax JR, Polzin WJ, Watson WJ. 2009. Pregnancy complicated by triploidy: A comparison of the three karyotypes. Am J Perinatol 26:641-645.
40. Moran CJ, Tay JB, Morrison JJ. 2002. Ultrasound detection and perinatal outcome of fetal trisomies 21, 18 and 13 in the absence of a routine fetal anomaly scan or biochemical screening. Ultrasound Obstet Gynecol 20:482-485.
41. Morris JK, Savva GM. 2008. The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18. Am J Med Genet Part A 146A:827-832.
42. Naguib KK, Al-Awadi SA, Moussa MA, Bastaki L, Gouda S, Redha MA, Mustafa F, Tayel SM, Abulhassan SA, Murthy DS. 1999. Trisomy 18 in Kuwait. Int J Epidemiol 28:711-716.
43. Nembhard WN, Waller DK, Sever LE, Canfield MA. 2001. Patterns of first-year survival among infants with selected congenital anomalies in Texas, 1995-1997. Teratology 64:267-275.
44. Niedrist D, Riegel M, Achermann J, Schinzel A. 2006. Survival with trisomy 18-Data from Switzerland. Am J Med Genet Part A 140A:952-959.
45. Niemann-Seyde SC, Rehder H, Zoll B. 1993. A case of full triploidy (69, XXX) of paternal origin with unusually long survival time. Clin Genet 43:79-82.
46. O'Connor C. 2008. Chromosomal abnormalities: Aneuploidies. Nature Education 1(1): 25.08.2011.
47. Parker MJ, Budd JL, Draper ES, Young ID. 2003. Trisomy 13 and trisomy 18 in a defined population: Epidemiological, genetic and prenatal observations. Prenat Diagn 23:856-860.
48. Philipp T, Grillenberger K, Separovic ER, Philipp K, Kalousek DK. 2004. Effects of triploidy on early human development. Prenat Diagn 24:276-281.
49. Pryde PG, Drugan A, Johnson MP, Isada NB, Evans MI. 1993. Prenatal diagnosis: Choices women make about pursuing testing and acting on abnormal results. Clin Obstet Gynecol 36:496-509.
50. Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM. 2003. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 111:777-784.
51. Romsberg TL. 2007. Building a case for neonatal palliative care. Neonatal Netw 26:111-115.
52. Root S, Carey JC. 1994. Survival in trisomy 18. Am J Med Genet 49:170-174.
53. Shaffer BL, Caughey AB, Norton ME. 2006. Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy. Prenat Diagn 26:667-671.
54. Sherard J, Bean C, Bove B, DelDuca V, Esterly KL, Karcsh HJ, Munshi G, Reamer JF, Suazo G, Wilmoth D, Dahlke MB, Weiss C, Borgaonkar DS, Reynolds JF. 1986. Long survival in a 69, XXY triploid male. Am J Med Genet 25:307-312.
55. Smith DW. 1964. Autosomal abnormalities. Am J Obstet Gynecol 90:1055-1077.
56. Souka AP, Michalitsi VD, Skentou H, Euripioti H, Papadopoulos GK, Kassanos D, Messinis IE, Salamalekis EE. 2010. Attitudes of pregnant women regarding termination of pregnancy for fetal abnormality. Prenat Diagn 30:977-980.
57. Tantravahi U, Bianchi DW, Haley C, Destrempes MM, Ricker AT, Korf BR, Latt SA. 1986. Use of Y chromosome specific probes to detect low level sex chromosome mosaicism. Clin Genet 29:445-448.
58. Vendola C, Canfield M, Daiger SP, Gambello M, Hashmi SS, King T, Noblin SJ, Waller DK, Hecht JT. 2010. Survival of Texas infants born with trisomies 21, 18 and 13. Am J Med Genet Part A 152A:360-366.
59. Warburton D, Kline J, Kinney A. 1994. No maternal age relationship for polyploidy. Hum Genet 93:725-726.
60. Weber WW. 1967. Survival and the sex ratio in trisomy 17-18. Am J Hum Genet 19:369-377.
61. Won RH, Currier RJ, Lorey F, Towner DR. 2005. The timing of demise in fetuses with trisomy 21 and trisomy 18. Prenat Diagn 25:608-611.
62. Yamanaka M, Setoyama T, Igarashi Y, Kurosawa K, Itani Y, Hashimoto S, Saitoh K, Takei M, Hirabuki T. 2006. Pregnancy outcome of fetuses with trisomy 18 identified by prenatal sonography and chromosomal analysis in a perinatal center. Am J Med Genet A 140A:1177-1182.
63. Young ID, Cook JP, Mehta L. 1986. Changing demography of trisomy 18. Arch Dis Child 61:1035-1036.